Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1478.8000 54.40 (3.82%)
NSE Oct 26, 2026 13:28 PM
Volume: 88,286
 

1478.80
3.82%

Four straight post-IPO beats; execution remains stellar

Motilal Oswal
Rubicon Research (RUBICON) delivered its fourth consecutive earnings surprise since its IPO (4%/13%/16% beat on revenue/EBITDA/PAT)—a strong pattern of promise vs consistent superior execution.
Number of MF schemes increased from 14 to 20 in Sep 2026 qtr.
More from Rubicon Research Ltd.
Recommended